Metagenomi, Inc. Common StockMGXNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 80% recommend buying.

Consensus Rating

Buy

5 analysts·Limited coverage

80%

Rating Distribution

Strong Buy

00%

Buy

480%

Hold

120%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 842% higher.

Bear Case

$7.00

+355%

Consensus

$14.50

+842%

Bull Case

$22.00

+1329%

Price Range5 analysts

Low

Consensus

High

$7.00

$22.00

Current Target

Current Price

$1.54

Upside to Target

$12.96

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-1.82(4 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev-6.73%

EPS—

FY2028

Rev-40.37%

EPS—

FY2029

Rev+40.90%

EPS—

Earnings Surprises

Beat rate:63%(5/8 quarters)

Avg surprise:+19.2%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Aug 21, 2024H.C. Wainwright

Metagenomi price target lowered to $7 from $10 at H.C. Wainwright

Target:$7.00

+112.1%from $3.30

Mar 28, 2024Jefferies

Metagenomi Inc (MGX) PT Lowered to $22 at Jefferies

Target:$22.00

+98.4%from $11.09

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance